India's hospitals reel from outpatient slump | Healthcare Asia Magazine
, India

India's hospitals reel from outpatient slump

People have been reluctant to visit hospitals out of fear of the pandemic.

Corporate hospitals in India will face pressure on their income as the pandemic and subsequent lockdowns caused a decline in outpatient footfall, according to a CARE Ratings report.

The outpatient department (OPD) volumes have been adversely impacted due to the reluctance of people to visit hospitals, out of fear of getting infected from other patients. Patients in medical tourism have also completely dried up due to the lockdowns.

Further, the Ministry of Health and Family Welfare (MoHFW) has issued an advisory to postpone elective and non-essential surgeries, asking hospitals to discourage patients to visit OPD or instead utilise OPD services in primary or secondary care facilities rather than crowding tertiary care centres.

As elective surgeries are mostly an outcome of OPD visits, the IPD segment has witnessed a significant decline in the occupancy levels.

Hospitals could only expect an uptick in occupancy levels not until the latter half of FY 2021 once the lockdowns are lifted and the public at large starts visiting hospitals for elective treatments.

CARE Ratings projected that there has been a plunge in occupancy level by 40- 50%, and the average occupancy levels for many corporate hospitals have come down to the range of 30-40%.

Even before the lockdowns, India’s corporate hospitals were already reeling from the 70% slash in the price of stents and knee implants in 2018. Hospitals traditionally were making around two-third of profits from such consumables. 

Pemindaian AI terkini meningkatkan diagnosa di Shin Kong Wu Ho-Su Memorial Hospital

Rumah sakit di Taiwan ini menggunakan teknologi endoskop yang dibantu AI untuk mendeteksi polip dan kamera resolusi tinggi untuk telemedis.

Kejeniusan dalam ‘SuperApps’ untuk perawatan kesehatan adalah akses dan jangkauan

Rumah sakit yang merangkul digitalisasi tetap unggul dalam layanan kesehatan.

Rumah Sakit Kanker Dharmais memimpin inovasi pelayanan kanker di Indonesia

Direktur Utama RS Kanker Dharmais Soeko Werdi Nindito Daroekoesoemo mengungkapkan teknologi canggih dan tujuh program unggulan untuk perawatan kanker.

Healthway Cancer Care Hospital memajukan perawatan holistik dengan harga yang wajar

Rumah sakit mengharapkan program kualitas dan kelangsungan hidup yang melayani keseluruhan perjalanan pasien.

MakatiMed menuju perawatan bedah presisi dengan sistem robotik Da Vinci Xi

Teknologi ini memungkinkan teknik invasif minimal dalam bidang urologi, hepatobilier, kardiovaskular, toraks, kebidanan dan ginekologi, serta bedah umum.

Indonesia memperluas dukungan solusi kesehatan menggunakan AI

Kolaborasi dengan Google Cloud sejalan dengan cetak biru pemerintah untuk transformasi kesehatan digital.

Indonesia merancang rencana induk untuk pengembangan kesehatan terpadu

Rencana induk sektor kesehatan negara (RIBK) selaras dengan mandat Undang-Undang Kesehatan Nomor 17 Tahun 2023.

The Medical City membuka jalan bagi integrasi AI dalam layanan kesehatan lokal dan penelitian dengan Lunit

AI telah diintegrasikan ke dalam layanan mamografi dan rontgen dada di jaringan rumah sakit ini.

Mayapada Healthcare Group meraih prestasi besar di Healthcare Asia Awards 2024

Pendekatan holistik yang dilakukan oleh rumah sakit tersebut mendorongnya maju dan menjadi standar industri.

Rumah Sakit Kanker Dharmais meraih dua kemenangan di Healthcare Asia Awards 2024

Sumber daya manusia yang kompeten, layanan, fasilitas, dan infrastruktur unggul membantu rumah sakit memberikan perawatan pasien yang sangat baik.